Pharma launches face tougher conditions post-pandemic, with faster cadences, tighter budgets, and disrupted patient journeys reducing ROI and delaying access. Patient engagement and support (PES) programs can provide a critical edge by addressing unmet needs across awareness, diagnosis, initiation, and adherence. Many current programs fall short by focusing too narrowly on treatment start, missing early education or long-term support. Case studies show how PES reduced prescription delays, expanded diagnostic capacity, supported caregivers, and improved adherence. Effective PES eases system burdens, boosts patient outcomes, and drives sustainable launch performance.

Join for free to read